Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia

Ibrutinib (Imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.

Saved in:
Bibliographic Details
Published in:P&T (Lawrenceville, N.J.) N.J.), 2014-07, Vol.39 (7), p.483-519
Main Authors: Parmar, Sapna, Patel, Khilna, Pinilla-Ibarz, Javier
Format: Article
Language:English
Subjects:
Departments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ibrutinib (Imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.
ISSN:1052-1372